Johnson & Johnson hit with $1B-plus jury verdict on faulty hip implants

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Johnson & Johnson (NYSE:JNJ) is ordered by a federal jury in Dallas to pay more than $1B to six plaintiffs who said they were injured by Pinnacle hip implants.

The jurors said the hip implants were defectively designed and that JNJ and its DuPuy Orthopaedics unit failed to warn patients about the risks.

JNJ, which still faces nearly 9K lawsuits over the implants, stopped selling the product in 2013 after the FDA toughened regulations on artificial hips; it plans to appeal the verdict.